BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Class B Common Stock
Symbol
BIO on NYSE
Shares outstanding
5,071,025
Price per share
$302.99
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
16,324,083
Total reported value
$4,946,314,745
% of total 13F portfolios
0%
Share change
+698,190
Value change
+$213,932,349
Number of holders
311
Price from insider filings
$302.99
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SCHWARTZ NORMAN D 97% $1,382,052,897 4,929,036 Norman D. Schwartz 25 Sep 2025
SCHWARTZ ALICE N 12% $659,303,856 2,732,073 Alice N. Schwartz 01 May 2025
First Eagle Investment Management, LLC 11% +14% $657,060,173 +$60,827,513 2,528,321 +10% First Eagle Investment Management, LLC 30 Jun 2025
VANGUARD GROUP INC 8.4% $462,850,693 1,907,640 The Vanguard Group - 23-1945930 30 Sep 2024
BlackRock, Inc. 7.4% $453,705,832 1,618,123 BlackRock, Inc. 30 Sep 2025

As of 31 Dec 2025, 311 institutional investors reported holding 16,324,083 shares of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO). This represents 322% of the company’s total 5,071,025 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) together control 267% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
First Eagle Investment Management, LLC 51% 2,570,473 +2% 1.4% $778,827,760
VANGUARD GROUP INC 35% 1,774,263 -1.1% 0.01% $537,583,947
BlackRock, Inc. 33% 1,680,948 -0.88% 0.01% $509,310,344
DIMENSIONAL FUND ADVISORS LP 21% 1,077,072 +1.3% 0.07% $326,343,765
ARIEL INVESTMENTS, LLC 15% 764,672 -5.5% 2.5% $231,687,970
EARNEST PARTNERS LLC 12% 603,594 -0.93% 0.78% $182,882,946
STATE STREET CORP 11% 559,604 -2.1% 0.01% $169,554,416
Capital Research Global Investors 9.8% 494,472 +18% 0.03% $149,820,071
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 7.9% 399,207 +4534% 0.04% $120,955,730
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 7.8% 395,077 -0.53% 0.03% $119,704,381
GEODE CAPITAL MANAGEMENT, LLC 6.7% 338,328 -3.4% 0.01% $102,531,269
SEI INVESTMENTS CO 5.8% 291,914 +3.3% 0.09% $88,445,447
FULLER & THALER ASSET MANAGEMENT, INC. 5.1% 259,577 +9.1% 0.27% $78,649,137
PARNASSUS INVESTMENTS, LLC 5% 252,140 -20% 0.2% $76,395,899
Boston Partners 4.9% 247,612 0.08% $75,037,041
Mawer Investment Management Ltd. 4.6% 233,946 -3.9% 0.4% $70,883,299
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ 4.5% 227,630 -4.1% 3.1% $68,969,614
UBS Group AG 4.3% 216,186 -6.3% 0.01% $65,502,197
THOMPSON SIEGEL & WALMSLEY LLC 3.8% 191,961 -12% 0.98% $58,162,000
MORGAN STANLEY 3.7% 186,386 +7.1% 0% $56,473,525
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3.6% 180,389 +0.24% 0.01% $54,656,063
GW&K Investment Management, LLC 3.5% 177,083 -3.7% 0.46% $53,655,000
WESTFIELD CAPITAL MANAGEMENT CO LP 3.3% 165,107 +6.2% 0.21% $50,025,770
FRANKLIN RESOURCES INC 2.7% 137,217 +14% 0.01% $41,575,380
Fisher Asset Management, LLC 2.6% 131,094 -1.8% 0.01% $39,720,169

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 16,324,083 $4,946,314,745 +$213,932,349 $302.99 311
2025 Q3 19,457,748 $5,457,457,914 +$102,626,216 $280.39 389
2025 Q2 19,201,217 $4,634,744,932 +$3,469,914 $241.32 380
2025 Q1 19,188,664 $4,671,911,959 +$52,969,583 $243.56 429
2024 Q4 18,778,253 $6,169,336,505 -$215,682,627 $328.51 450
2024 Q3 19,370,183 $6,481,921,085 -$218,781,622 $334.58 433
2024 Q2 19,799,636 $5,407,155,613 +$314,233,620 $273.11 428
2024 Q1 18,483,713 $6,388,531,345 +$32,714,858 $345.87 456
2023 Q4 18,529,807 $5,981,150,118 -$116,305,124 $322.89 479
2023 Q3 18,786,490 $6,730,924,381 -$58,698,141 $358.45 466
2023 Q2 18,297,158 $6,935,982,346 -$192,100,378 $379.12 463
2023 Q1 19,221,018 $9,200,944,144 +$12,069,903 $479.02 499
2022 Q4 19,259,738 $8,110,380,673 -$117,736,871 $420.49 467
2022 Q3 19,487,538 $8,135,809,192 +$113,970,897 $417.14 471
2022 Q2 19,114,362 $9,462,174,468 +$34,485,329 $495.00 489
2022 Q1 19,167,385 $10,796,615,316 -$34,402,167 $563.23 505
2021 Q4 19,102,716 $14,417,922,909 -$389,707,592 $755.57 521
2021 Q3 19,387,789 $14,451,450,076 +$60,848,148 $745.95 500
2021 Q2 19,381,230 $12,476,219,166 -$119,629,052 $644.29 496
2021 Q1 19,617,764 $11,195,376,908 -$8,883,384 $571.17 483
2020 Q4 19,657,768 $11,449,028,308 +$302,277,766 $582.94 483
2020 Q3 19,264,413 $9,927,181,928 +$28,169,224 $515.46 471
2020 Q2 19,228,922 $8,674,553,754 +$210,745,728 $451.49 461
2020 Q1 18,823,652 $6,598,533,578 -$18,322,057 $350.56 400
2019 Q4 18,896,407 $6,990,274,305 -$73,846,893 $370.03 378
2019 Q3 19,229,050 $6,397,950,795 +$147,523,371 $332.74 349
2019 Q2 18,689,418 $5,839,484,014 -$162,235,104 $312.59 326
2019 Q1 19,427,855 $5,938,774,395 +$26,520,823 $305.68 340
2018 Q4 19,085,794 $4,431,741,573 -$63,728,134 $232.22 319
2018 Q3 18,915,230 $5,919,673,702 +$12,116,363 $312.99 336
2018 Q2 19,093,330 $5,509,358,014 -$50,946,485 $288.54 321
2018 Q1 19,293,335 $4,824,798,687 +$32,427,500 $250.08 310
2017 Q4 19,199,238 $4,582,088,596 +$7,406,998 $238.67 297
2017 Q3 19,186,971 $4,263,280,405 +$85,006,470 $222.22 268
2017 Q2 18,803,522 $4,255,482,844 -$40,486,301 $226.31 274
2017 Q1 19,038,767 $3,796,416,375 +$212,751,881 $199.34 270
2016 Q4 19,724,001 $3,595,615,783 +$105,010,927 $182.28 255
2016 Q3 19,083,435 $3,125,213,054 +$688,135 $163.81 235
2016 Q2 19,112,947 $2,733,970,889 +$70,361,251 $143.02 233
2016 Q1 18,593,481 $2,543,249,593 -$28,652,347 $136.72 227
2015 Q4 18,814,885 $2,609,135,116 -$16,649,584 $138.66 237
2015 Q3 18,827,519 $2,528,738,077 +$40,719,556 $134.31 241
2015 Q2 18,681,380 $2,812,961,739 -$21,728,607 $150.61 221
2015 Q1 18,867,726 $2,549,214,332 +$11,434,191 $135.18 216
2014 Q4 18,830,474 $2,270,334,287 +$17,595,205 $120.56 213
2014 Q3 18,587,460 $2,107,510,068 +$35,450,758 $113.40 198
2014 Q2 18,276,691 $2,186,453,716 +$17,844,667 $119.71 201
2014 Q1 18,092,627 $2,316,027,490 -$19,637,838 $128.12 189